Oct 6 (Reuters) - Insight Molecular Diagnostics Inc IMDX.O:
IMDX REPORTS KIDNEY TRANSPLANT PATIENT ACHIEVED ‘IMMUNE RESET’ WITH NOVEL THERAPY AND GRAFTASSURE MONITORING
Source text: ID:nGNXYFDTG
Further company coverage: IMDX.O
((Reuters.Briefs@thomsonreuters.com;))